BETTER-Dx: Bringing Efficiency to the Early Alzheimer’s Disease Diagnosis: Digital Cognitive Assessments – A Real-World Study

Eisai Clinical Trials

Protocol # R2000-M001-013

Study Overview

Study Compound: N/A

Drug Name: N/A

Registry #: N/A

Trial Period: May 2026 - Sep 2027

Indication: Early Alzheimer's Disease

Primary Endpoint: 1. Time (in days) from the initial cognitive complaint or concern to confirmed diagnosis
of AD or MCI due to AD

Population
Males and females 50 Years and older (Adult, Older Adult)
Study Status
Ongoing
Study Phase
Phase N/A
Countries
United States

Clinical Trial Documents

Clinical Study Report Synopsis

No download available

Plain Language Protocol Synopsis (PLPS)

No download available

Plain Language Summary of Results (PLS)

No download available

Publication reference citation

Data Sharing

ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.

CSDR Sharing is not available for this study.

CSDR	Availability
Clinical Trial Data

Redacted documents may be available upon request for this study.

Document type	Availability
Protocol
SAP
Sample CRF
Full CSR